Osteopetrosis Archives - PharmaLive

Ligand Buys Pfenex in $516 Million Deal

Acquisitions, Biosimilars, Business, Committee for Medicinal Products for Human Use (CHMP), Deals, European Commission, Osteopetrosis, Positive Opinions, Postmenopausal, Product Pipelines, Proteins, Quarterly results, Shares, Therapeutics

San Diego-based Ligand Pharmaceuticals is acquiring San Diego-based Pfenex for a total deal transaction of up to $516 million.

August 12, 2020/by Andrew Humphreys